Insider Stock Trading History of Almon Einat Brill


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Almon Einat Brill since year 2005. The trader's CIK number is 1385116. At the time of this reporting, Almon Einat Brill is the VP, Product Developm of Protalix Biotherapeutics, Inc. . (stock ticker symbol PLX). See this page for all insider trading activities at Protalix Biotherapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Almon Einat Brill since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-05-02 PLX Protalix Biotherapeutics, Inc. Option Ex 166,848 1.81 302,161
2012-05-02 PLX Protalix Biotherapeutics, Inc. Sale 166,848 7.13 1,189,626
2010-10-06 PLX Protalix Biotherapeutics, Inc. Sale 15,000 9.29 139,350
2010-10-05 PLX Protalix Biotherapeutics, Inc. Sale 20,000 9.08 181,600
2010-10-06 PLX Protalix Biotherapeutics, Inc. Option Ex 70,000 .97 68,040
2010-10-04 PLX Protalix Biotherapeutics, Inc. Sale 35,000 9.02 315,700
2010-09-03 PLX Protalix Biotherapeutics, Inc. Sale 27,500 8.00 220,000
2010-09-07 PLX Protalix Biotherapeutics, Inc. Option Ex 50,000 .69 34,300
2010-09-07 PLX Protalix Biotherapeutics, Inc. Sale 22,500 8.16 183,600
2009-10-16 PLX Protalix Biotherapeutics, Inc. Sale 23,680 9.39 222,355
2009-10-19 PLX Protalix Biotherapeutics, Inc. Option Ex 93,954 .40 37,487
2009-10-19 PLX Protalix Biotherapeutics, Inc. Sale 38,320 9.43 361,357
2009-10-15 PLX Protalix Biotherapeutics, Inc. Sale 28,000 9.39 262,920
2009-07-07 PLX Protalix Biotherapeutics, Inc. Sale 11,000 4.95 54,450
2009-07-06 PLX Protalix Biotherapeutics, Inc. Sale 44,000 5.13 225,720
2009-07-07 PLX Protalix Biotherapeutics, Inc. Option Ex 59,822 .40 23,868
2009-05-18 PLX Protalix Biotherapeutics, Inc. Sale 40,000 4.00 160,000
2009-05-18 PLX Protalix Biotherapeutics, Inc. Option Ex 44,707 .40 17,838
2008-05-11 PLX Protalix Biotherapeutics, Inc. Option Ex 48,370 .40 19,251
2008-05-12 PLX Protalix Biotherapeutics, Inc. Sale 41,427 2.75 113,924

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Almon Einat Brill (VP, Product Developm of Protalix Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.